• From Variant Breadth to Assay Confidence

  2026-09-19

  Broad-spectrum vaccine concepts require equally disciplined measurement strategies. This thought-leadership article connects the RQ3025 preclinical evidence with translational assay design and shows how HyperFluor 488 Goat Anti-Human IgG (H+L) Antibody can support sensitive human IgG detection across fluorescence-based workflows.

• Syringin Targets EGFR/PI3K/Akt in RCC

  2026-09-19

  A 2024 Journal of Functional Foods study identifies Syringin as a potential renal cell carcinoma sensitizer that suppresses malignant cell behaviors and improves sunitinib activity. By combining network pharmacology, molecular docking, cell-based assays, apoptosis analysis, and Western blotting, the researchers connect these effects with EGFR/PI3K/Akt pathway modulation while highlighting the need for further validation beyond cell models.

• 4-Hydroxytamoxifen: Practical Protocol and QC Guide

  2026-09-18

  This guide explains how to prepare, store, and qualify 4-Hydroxytamoxifen for DMSO-based estrogen receptor modulation workflows. It is appropriate for controlled breast cancer research, prostate cancer research, apoptosis assays, and cardiac studies, but should not be selected for protocols requiring aqueous or ethanol solubilization or an unverified paper-matched dose schedule.

• FAISL–FAK Proteolysis in Triple-Negative Breast Cancer

  2026-09-17

  The reference study identifies FAISL as a long noncoding RNA that stabilizes focal adhesion kinase by blocking Calpain 2-mediated proteolysis, thereby promoting aggressive triple-negative breast cancer behavior. Its combination of transcriptomic discovery, mechanistic protein analysis, functional assays, and nanoparticle-mediated in vivo silencing provides a framework for studying post-translational control of FAK beyond kinase activity.

• Gepotidacin: From Topoisomerase Biology to Translation

  2026-09-17

  Gepotidacin, also known as GSK2140944, illustrates how a differentiated bacterial topoisomerase mechanism can be translated from biochemical assays into resistance-aware clinical development. This article connects target biology, experimental design, comparator strategy, and the implications of the EAGLE-2 and EAGLE-3 uUTI trial protocols for modern antibacterial research.

• BMS 309403: FABP4 Inhibitor Workflow Guide

  2026-09-17

  Use BMS 309403 as a mechanistic probe of FABP4-dependent lipid handling, macrophage inflammation, and foam cell formation. This workflow connects concentration planning, SERCA2 dysfunction models, orthogonal readouts, and troubleshooting for atherosclerosis and metabolic disease studies.

• HOTAIR–miR-30a-5p–PDE7A in ARDS

  2026-09-16

  The reference study identifies a regulatory pathway in which HOTAIR knockdown protects against LPS-induced inflammatory injury through the miR-30a-5p/PDE7A axis. By combining cellular perturbation, reporter validation, and a mouse ARDS model, the work moves beyond expression profiling toward a testable mechanistic framework, while remaining preclinical.

• Sodium Ascorbate in ROS-Driven Cancer Assays

  2026-09-15

  Sodium Ascorbate enables controlled redox-stress experiments in glioblastoma and other cancer-cell models, with solvent-aware workflows that help separate ROS effects from vehicle artifacts. This guide connects practical cytotoxicity assays with the GPNMB-centered immunotherapy framework reported in esophageal squamous cell carcinoma, while clearly distinguishing established findings from exploratory extensions.

• HotStart 2X Green qPCR Master Mix for Sepsis

  2026-09-15

  HotStart 2X Green qPCR Master Mix supports rigorous SYBR Green analysis of exosomal miRNA in sepsis research. This article presents an assay-decision framework linking preanalytical control, mechanistic validation, and reproducible nucleic acid quantification.

• Estradiol Benzoate: ERα Assay Workflows

  2026-09-14

  Estradiol Benzoate provides a practical reference agonist for connecting direct ERα binding with cell-based estrogen receptor-mediated signaling. This workflow emphasizes solvent control, concentration design, orthogonal validation, and troubleshooting across human, murine, and chicken research models.

• Biotin-16-UTP: Reliable RNA Assay Workflows

  2026-09-14

  This scenario-based guide explains how Biotin-16-UTP (SKU B8154) supports reproducible in vitro transcription RNA labeling, RNA detection and purification, and RNA-protein interaction studies relevant to cell proliferation and cytotoxicity research. It also distinguishes documented product specifications from workflow recommendations and direct viability-assay evidence.

• AM251 as a Causal Probe in Pain Research

  2026-09-13

  AM251 is a CB1 receptor antagonist that can help separate receptor-proximal signaling from circuit and behavioral effects. This article develops an assay-centered framework linking AM251 pharmacology with recent cannabidiol research in inflammatory pain, affect, and cognition.

• Biotin-16-UTP: RNA Labeling Workflow Guide

  2026-09-12

  Biotin-16-UTP provides a biotin-labeled uridine triphosphate for incorporating an affinity handle into RNA during in vitro transcription, supporting RNA detection and purification workflows. It is intended for research optimization only; the dossier does not establish application-specific yields, incorporation rates, diagnostic performance, or a universal protocol.

• LGK-974: PORCN Inhibitor for Wnt Research

  2026-09-12

  LGK-974 is a potent, selective PORCN inhibitor and Wnt signaling pathway inhibitor for research on ligand-dependent Wnt biology. Product data report nanomolar pathway inhibition and activity in RNF43-mutant pancreatic cancer models, while developmental evidence supports careful separation of Wnt biology from compound-specific efficacy.

• Ceftolozane Sulfate Research Workflows

  2026-09-11

  Build reproducible susceptibility, bactericidal, and PK/PD experiments around Ceftolozane sulfate for Pseudomonas aeruginosa and selected Enterobacterales. This guide connects assay design with resistance interpretation, animal-model translation, and practical troubleshooting while distinguishing ceftolozane-alone data from ceftolozane-tazobactam evidence.

8658 records 1/578 page Next 12345 下5页 Last page